Dianthus Therapeutics, Inc. (DNTH)
87.35
-0.45
(-0.51%)
USD |
NASDAQ |
May 01, 16:00
87.35
0.00 (0.00%)
After-Hours: 17:43
Dianthus Therapeutics Market Cap : 4.624B for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Madrigal Pharmaceuticals, Inc. | 11.78B |
| Sarepta Therapeutics, Inc. | 2.256B |
| Daré Bioscience, Inc. | 34.29M |
| Relmada Therapeutics, Inc. | 803.46M |
| Viridian Therapeutics, Inc. | 1.369B |
Market Cap Related Metrics
| PS Ratio | 1655.82 |
| PEG Ratio | -0.3639 |
| Price to Book Value | 9.373 |
| Price | 87.35 |
| Earnings Yield | -4.71% |
| PEGY Ratio | -0.3639 |